Ondine Biomedical (LSE:OBI) EBIT per Share : £-0.04 (TTM As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Ondine Biomedical EBIT per Share?

Ondine Biomedical's EBIT per Share for the six months ended in Jun. 2024 was £-0.02. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was £-0.04.

During the past 3 years, the average EBIT per Share Growth Rate was 2.20% per year. During the past 5 years, the average EBIT per Share Growth Rate was -3.90% per year. During the past 10 years, the average EBIT per Share Growth Rate was 11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Ondine Biomedical's EBIT per Share or its related term are showing as below:

LSE:OBI' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -129.5 Med: -4.6 Max: 53.8
Current: 2.2

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Ondine Biomedical was 53.80% per year. The lowest was -129.50% per year. And the median was -4.60% per year.

LSE:OBI's 3-Year EBIT Growth Rate is ranked worse than
51.2% of 1250 companies
in the Biotechnology industry
Industry Median: 2.8 vs LSE:OBI: 2.20

Ondine Biomedical's EBIT for the six months ended in Jun. 2024 was £-4.44 Mil.

Ondine Biomedical EBIT per Share Historical Data

The historical data trend for Ondine Biomedical's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ondine Biomedical EBIT per Share Chart

Ondine Biomedical Annual Data

Trend

Dec08

Dec09

Dec10

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-0.04

-0.05

-0.36

-0.06

-0.04

Ondine Biomedical Semi-Annual Data
	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Jun11	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT per Share	Get a 7-Day Free Trial															-0.03	-0.03	-0.02	-0.02	-0.02

Ondine Biomedical EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Ondine Biomedical's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-8.464	/	197.112
=	-0.04

Ondine Biomedical's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

	EBIT per Share		(Q: Jun. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-4.439	/	241.469
=	-0.02

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.04

Ondine Biomedical (LSE:OBI) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Ondine Biomedical EBIT per Share Related Terms

Thank you for viewing the detailed overview of Ondine Biomedical's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Ondine Biomedical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ondine Biomedical Inc (LSE:OBI) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

OBIMF:USA VF5:Germany

Address

1100 Melville Street, Suite 888, Vancouver, BC, CAN, V6E4A6

Website

https://www.ondinebio.com

Ondine Biomedical Inc is a life sciences company, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. The company has created a platform technology called antimicrobial photodynamic disinfection, or photodisinfection, to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings. Canada is the major revenue generator for the group. The company has one reportable operating segment that is antimicrobial photodynamic therapy (aPDT) products.

Ondine Biomedical Headlines

No Headlines